Recent studies have shown that pediatric asthma patients possess lower levels of CD24+CD38+ regulatory B cells producing IL-10 compared to a control group, highlighting the significant role of an appropriate quantity and function of regulatory B cells in controlling allergic inflammation [86]. This evidence concerns the gene IL10 and asthma.